Showing 1 - 5 results of 5 for search 'Gulbanu Sarsenbayeva', query time: 0.03s Refine Results
  1. 1
    Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan

    Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan by Gulbanu Sarsenbayeva, Timur Issagulov, Markhabat Kassenov, Ruslan Abitay, Mukhit Orynbayev, Marina Stukova, Maria Pisareva, Timur Davlyatshin, Kutumbetov Lespek, Berik Khairullin

    Published 2020-08-01
    Get full text
    Article
  2. 2
    Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults

    Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adult... by Gulbanu Sarsenbayeva, Yevgeniy Volgin, Markhabat Kassenov, Timur Issagulov, Nikolay Bogdanov, Abylay Sansyzbay, Marina Stukova, Zhanna Buzitskaya, Ilyas Кulmagambetov, Timur Davlyatshin, Berik Khairullin

    Published 2018-03-01
    Get full text
    Article
  3. 3
    Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan

    Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase... by Kunsulu Zakarya, Lespek Kutumbetov, Mukhit Orynbayev, Yergali Abduraimov, Kulyaisan Sultankulova, Markhabat Kassenov, Gulbanu Sarsenbayeva, Ilyas Kulmagambetov, Timur Davlyatshin, Maria Sergeeva, Marina Stukova, Berik Khairullin

    Published 2021-09-01
    Get full text
    Article
  4. 4
    Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis

    Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis by Anna-Polina Shurygina, Natalia Zabolotnykh, Tatiana Vinogradova, Berik Khairullin, Markhabat Kassenov, Ainur Nurpeisova, Gulbanu Sarsenbayeva, Abylai Sansyzbay, Kirill Vasilyev, Janna Buzitskaya, Andrey Egorov, Marina Stukova

    Published 2023-04-01
    Get full text
    Article
  5. 5
    Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up

    Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 cl... by Berik Khairullin, Kunsulu Zakarya, Mukhit Orynbayev, Yergali Abduraimov, Markhabat Kassenov, Gulbanu Sarsenbayeva, Kulyaisan Sultankulova, Olga Chervyakova, Balzhan Myrzakhmetova, Aziz Nakhanov, Ainur Nurpeisova, Kuandyk Zhugunissov, Nurika Assanzhanova, Sergazy Nurabayev, Aslan Kerimbayev, Zakir Yershebulov, Yerbol Burashev, Ilyas Kulmagambetov, Timur Davlyatshin, Maria Sergeeva, Zhanna Buzitskaya, Marina Stukova, Lespek Kutumbetov

    Published 2022-08-01
    Get full text
    Article

Search Tools: